Aurobindo Pharma shareholders approve all resolutions at 38th AGM

Aurobindo Pharma Limited announced that all resolutions proposed at its 38th Annual General Meeting (AGM), held on September 10, 2025, were approved by shareholders with the requisite majority. The voting results, combining remote e-voting and e-voting during the AGM, were disclosed on September 11, 2025.

The resolutions included the adoption of the Audited Standalone and Consolidated Financial Statements for the financial year ended March 31, 2025, and the re-appointment of directors and the secretarial auditor. For the Audited Standalone Financial Statements, 99.95% of votes cast were in favor. Similarly, the Audited Consolidated Financial Statements also received 99.95% in favor.

Key re-appointment resolutions also passed with significant majorities. The re-appointment of Mr. P. Sarath Chandra Reddy saw 87.86% of votes in favor, while Dr. Satakarni Makkapati's re-appointment garnered 89.42% support. Finally, the appointment of the secretarial auditor received 98.14% of votes in favor. The total number of votes cast across all resolutions ranged from 493,539,921 to 510,450,285.